K-pop

Mixed-gender group KARD to make a comeback on the 28th with their first full-length album

"Where to Now? Part: Now Here" Released Follow-up to the 7th mini-album released in 2024

[Edaily Starin KIM HYUNSIK Reporter] The mixed-gender group KARD (BM, J.Seop, Jeon So-min, Jeon Ji-woo) is making a comeback with a full-length album.
(Photo courtesy of DSP Media)
According to their agency, DSP Media, on the 2nd, KARD will release their first full-length album, “Where To Now? Part.2: NOWHERE,” on the 28th.
This album serves as a follow-up to KARD’s seventh mini-album, “Where To Now? Part.1: Yellow Light,” released in August 2024.
On that day, KARD caught fans’ attention by releasing a teaser image on their official social media channels, showing a poster with details about their comeback album placed on asphalt scattered with colorful confetti.
An agency representative explained, “With this, their first full-length album since debut, KARD will conclude the ‘Where To Now?’ series, which posed the question ‘Where are we headed?’ and set a new musical milestone.”
Meanwhile, ahead of their comeback, KARD will hold a concert in Tokyo, Japan, on the 4th as part of their world tour “DRIFT.”

Economy

Corporation

IT·Science

Economy

A Semiconductor Fabless Company Founded by SK Hynix’s Youngest-Ever Executive [VC Cradle]

The biggest bottleneck for AI servers is memory. As the KV cache—where large language models (LLMs) store past computations—accumulates, the required memory capacity increases exponentially. This prob…
2026-07-04 09:00:07

Corporation

Genosco, Tax Risk?… “Lecraza Is ‘Royalty Income’; Its Value Remains Unchanged”

Concerns about “tax risks” have been raised in some quarters of the financial investment, pharmaceutical, and biotech markets regarding Genosco, a subsidiary of OSCOTEC Inc.(039200)specializing in new…
2026-07-04 08:31:02

IT·Science

Celltrion Pharm Inc. Builds a Plant, AriBio Secures Investment… K-Bio in ‘Expansion Mode’ [Weekly Bio Roundup]

As July began (June 29–July 3), the pharmaceutical and biotech industries turned their attention to Celltrion Pharm Inc.’s large-scale investment in production facilities and AriBio’s successful fundr…
2026-07-04 09:01:02